Ironwood Pharmaceuticals IRWD Deferred and other income taxes
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's deferred and other income taxes.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's deferred and other income taxes?
- Ironwood Pharmaceuticals (IRWD) reported deferred and other income taxes of $19.2M in Q1 2026.
- How has Ironwood Pharmaceuticals's deferred and other income taxes changed year-over-year?
- Ironwood Pharmaceuticals's deferred and other income taxes increased by 2765.1% year-over-year, from $670K to $19.2M.
- What is the long-term trend for Ironwood Pharmaceuticals's deferred and other income taxes?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's deferred and other income taxes has grown at a -40.2% compound annual growth rate (CAGR), from -$333.29M to $42.55M.